Lenalidomide Capsule
Product Images NDC 0480-1241

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lenalidomide (NDC 0480-1241). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 1)

Chemical structure diagram of lenalidomide, showing its molecular framework with labeled atoms including carbon, oxygen, nitrogen, and hydrogen groups.*

FDA Label Image

1 (Image 2)

A Kaplan-Meier survival curve chart depicting progression-free survival over months for three groups: Rd Continuous, Rd18, and MPT. The y-axis indicates survival probability (%) and the x-axis shows time in months. The chart includes hazard ratios, confidence intervals, log-rank p-value, and number of subjects at risk at different time points.*

FDA Label Image

1 (Image 3)

A survival probability Kaplan-Meier curve comparing overall survival (months) for three treatment groups labeled Rd Continuous, Rd18, and MPT. The graph shows survival probability on the vertical axis and overall survival time in months on the horizontal axis, with a table below presenting the number of subjects at risk for each group across time points. Hazard ratios (HR) with confidence intervals for pairwise group comparisons are also displayed.*

FDA Label Image

1 (Image 4)

A Kaplan-Meier survival curve depicting time to progression in months on the x-axis and proportion of subjects on the y-axis. The graph compares two groups: Lenalidomide/Dex and Placebo/Dex, showing higher progression-free survival for the Lenalidomide/Dex group over approximately 20 months. Hazard ratio and log-rank p-value are also displayed on the chart.*

FDA Label Image

1 (Image 5)

A Kaplan-Meier survival curve comparing time to progression (months) between two groups: Lenalidomide/Dexamethasone (Lenalidomide/Dex) and Placebo/Dexamethasone (Placebo/Dex). The y-axis represents the proportion of subjects, and the x-axis shows time to progression in months. The graph includes a hazard ratio (HR) with 95% confidence interval and a log-rank p-value.*

FDA Label Image

1 (Image 6)

Lenalidomide Capsules 5 mg label from Teva Pharmaceuticals, Inc. The label shows the 5 mg strength, packaging of 28 capsules, storage instructions, and a warning about potential human birth defects. It includes manufacturer details for Natco Pharma Limited in India and Teva Pharmaceuticals in New Jersey, along with a barcode and serialization coding area.*

FDA Label Image

1 (Image 7)

Label for Lenalidomide Capsules 10 mg by Teva Pharmaceuticals, Inc. The label includes storage instructions, a warning about potential human birth defects, directions for pharmacists to dispense a Medication Guide, and indicates the package contains 28 capsules. Manufacturing information specifies Natco Pharma Limited in India and Teva Pharmaceuticals in New Jersey.*

FDA Label Image

1 (Image 8)

Label for Lenalidomide capsules 15 mg by Teva Pharmaceuticals, Inc. The label includes dosage information, temperature storage instructions, a warning about potential for human birth defects, and instructions for pharmacists to dispense an accompanying Medication Guide. It indicates the product contains 21 capsules and shows NDC 0480-1244-21. Manufacturer information for Natco Pharma Limited in India and packaging details for Teva Pharmaceuticals in Parsippany, NJ are also present.*

FDA Label Image

1 (Image 9)

Label for Lenalidomide Capsules 25 mg by Teva Pharmaceuticals, Inc. The label shows storage instructions, NDC 0480-1246-21, and states this is a prescription drug. It includes a warning about potential human birth defects and directions for pharmacists to dispense a medication guide. The label indicates 21 capsules per package and manufacturing details in India by Natco Pharma Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.